CAH Quote, Financials, Valuation and Earnings

Cencora, Inc. has a net margin of 0.71% compared to Cardinal Health, Inc.'s net margin of -0.4%. Cardinal Health, Inc.'s return on equity of -- beat Cencora, Inc.'s return on equity of 124.72%.

Cardinal Health, Inc. has a consensus price target of $214.71, signalling upside risk potential of 7.51%. On the other hand Cencora, Inc. has an analysts' consensus of $384.79 which suggests that it could grow by 14.76%. Given that Cencora, Inc. has higher upside potential than Cardinal Health, Inc., analysts believe Cencora, Inc. is more attractive than Cardinal Health, Inc..

Cardinal Health, Inc. has a beta of 0.626, which suggesting that the stock is 37.423% less volatile than S&P 500. In comparison Cencora, Inc. has a beta of 0.632, suggesting its less volatile than the S&P 500 by 36.802%.

Cardinal Health, Inc. has a quarterly dividend of $0.51 per share corresponding to a yield of 1.02%. Cencora, Inc. offers a yield of 0.67% to investors and pays a quarterly dividend of $0.60 per share. Cardinal Health, Inc. pays 31.43% of its earnings as a dividend. Cencora, Inc. pays out 27.63% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Cardinal Health, Inc. quarterly revenues are $64B, which are smaller than Cencora, Inc. quarterly revenues of $83.7B. Cardinal Health, Inc.'s net income of $454M is higher than Cencora, Inc.'s net income of -$333.1M. Notably, Cardinal Health, Inc.'s price-to-earnings ratio is 30.15x while Cencora, Inc.'s PE ratio is 42.17x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cardinal Health, Inc. is 0.21x versus 0.20x for Cencora, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Henry Schein, Inc. has a net margin of 0.71% compared to Cardinal Health, Inc.'s net margin of 3.27%. Cardinal Health, Inc.'s return on equity of -- beat Henry Schein, Inc.'s return on equity of 8.47%.

Cardinal Health, Inc. has a consensus price target of $214.71, signalling upside risk potential of 7.51%. On the other hand Henry Schein, Inc. has an analysts' consensus of $77.00 which suggests that it could grow by 5.65%. Given that Cardinal Health, Inc. has higher upside potential than Henry Schein, Inc., analysts believe Cardinal Health, Inc. is more attractive than Henry Schein, Inc..

Cardinal Health, Inc. has a beta of 0.626, which suggesting that the stock is 37.423% less volatile than S&P 500. In comparison Henry Schein, Inc. has a beta of 0.887, suggesting its less volatile than the S&P 500 by 11.251%.

Cardinal Health, Inc. has a quarterly dividend of $0.51 per share corresponding to a yield of 1.02%. Henry Schein, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cardinal Health, Inc. pays 31.43% of its earnings as a dividend. Henry Schein, Inc. pays out -- of its earnings as a dividend. Cardinal Health, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Cardinal Health, Inc. quarterly revenues are $64B, which are larger than Henry Schein, Inc. quarterly revenues of $3.3B. Cardinal Health, Inc.'s net income of $454M is higher than Henry Schein, Inc.'s net income of $109M. Notably, Cardinal Health, Inc.'s price-to-earnings ratio is 30.15x while Henry Schein, Inc.'s PE ratio is 23.03x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cardinal Health, Inc. is 0.21x versus 0.70x for Henry Schein, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

McKesson Corp. has a net margin of 0.71% compared to Cardinal Health, Inc.'s net margin of 1.13%. Cardinal Health, Inc.'s return on equity of -- beat McKesson Corp.'s return on equity of --.

Cardinal Health, Inc. has a consensus price target of $214.71, signalling upside risk potential of 7.51%. On the other hand McKesson Corp. has an analysts' consensus of $934.79 which suggests that it could grow by 16.07%. Given that McKesson Corp. has higher upside potential than Cardinal Health, Inc., analysts believe McKesson Corp. is more attractive than Cardinal Health, Inc..

Cardinal Health, Inc. has a beta of 0.626, which suggesting that the stock is 37.423% less volatile than S&P 500. In comparison McKesson Corp. has a beta of 0.382, suggesting its less volatile than the S&P 500 by 61.811%.

Cardinal Health, Inc. has a quarterly dividend of $0.51 per share corresponding to a yield of 1.02%. McKesson Corp. offers a yield of 0.38% to investors and pays a quarterly dividend of $0.82 per share. Cardinal Health, Inc. pays 31.43% of its earnings as a dividend. McKesson Corp. pays out 10.69% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Cardinal Health, Inc. quarterly revenues are $64B, which are smaller than McKesson Corp. quarterly revenues of $103.2B. Cardinal Health, Inc.'s net income of $454M is lower than McKesson Corp.'s net income of $1.2B. Notably, Cardinal Health, Inc.'s price-to-earnings ratio is 30.15x while McKesson Corp.'s PE ratio is 25.07x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cardinal Health, Inc. is 0.21x versus 0.26x for McKesson Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Pineapple, Inc. has a net margin of 0.71% compared to Cardinal Health, Inc.'s net margin of -40.74%. Cardinal Health, Inc.'s return on equity of -- beat Pineapple, Inc.'s return on equity of --.

Cardinal Health, Inc. has a consensus price target of $214.71, signalling upside risk potential of 7.51%. On the other hand Pineapple, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Cardinal Health, Inc. has higher upside potential than Pineapple, Inc., analysts believe Cardinal Health, Inc. is more attractive than Pineapple, Inc..

Cardinal Health, Inc. has a beta of 0.626, which suggesting that the stock is 37.423% less volatile than S&P 500. In comparison Pineapple, Inc. has a beta of 40.248, suggesting its more volatile than the S&P 500 by 3924.762%.

Cardinal Health, Inc. has a quarterly dividend of $0.51 per share corresponding to a yield of 1.02%. Pineapple, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cardinal Health, Inc. pays 31.43% of its earnings as a dividend. Pineapple, Inc. pays out -- of its earnings as a dividend. Cardinal Health, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Cardinal Health, Inc. quarterly revenues are $64B, which are larger than Pineapple, Inc. quarterly revenues of $2.7K. Cardinal Health, Inc.'s net income of $454M is higher than Pineapple, Inc.'s net income of -$1.1K. Notably, Cardinal Health, Inc.'s price-to-earnings ratio is 30.15x while Pineapple, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cardinal Health, Inc. is 0.21x versus 38.61x for Pineapple, Inc.. Usually stocks with elevated PS ratios are considered overvalued.